Latest Glue News & Updates

See the latest news and media coverage for Glue. We track all announcements, press releases, and industry mentions in real time, all in one place.

Glue

Virtual collaboration platform

glue.work

Headquarters: Helsinki, Finland
Founded year: 2017
Company type: Private company
Number of employees: 10–50

Last updated Today

Latest news about Glue

In short: Glue was acquired by Hyperspace and expanded its presence in the virtual collaboration and enterprise XR markets.

Company announcements

January 29 Glue

Glue announces Horizon Workrooms ends February 16 2026

Teams relying on persistent rooms must save artifacts. Glue provides a step-by-step migration guide and checklist.

7 November 2024 Glue

Glue supports PZU's transformation in team collaboration

Glue is collaborating with PZU to redefine meetings and adult education through innovative virtual and immersive technologies.

10 October 2024 Glue

Glue highlights collaboration at Universität Münster in the Metaverse

Students and professors engaged in spontaneous, meaningful virtual connections showcasing spatial collaboration's potential beyond traditional video calls. Leadership emphasized immersive remote teamwork experiences.

3 June 2024 Glue

Glue has been acquired by Hyperspace

Hyperspace completed its acquisition of Glue, promising continued service and enhanced virtual collaboration tools for users.

Media coverage

May 7 Quiver Quantitative

MONTE ROSA THERAPEUTICS ($GLUE) Releases Q1 2026 Earnings | Quiver Quantitative

MONTE ROSA THERAPEUTICS ($GLUE) posted quarterly earnings results for Q1 2026 on Thursday, May 7th. The company reported earnings of -$0.45 per share, missing estimates...

April 27 Yahoo Finance

Erasca to Host Conference Call and Webcast to Discuss Preliminary Phase 1 Dose Escalation Data for Potentially Best-in-Class Pan-RAS Molecular Glue ERAS-0015

PM Eastern TimeSAN DIEGO, April 27, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and...

April 9 Yahoo Finance

Kymera Therapeutics Announces Gilead Sciences' Option Exercise to License KT-200, Oral CDK2 Molecular Glue Degrader Development Candidate

KT-200 is a first-in-class, oral CDK2 molecular glue degrader development candidate Option exercise of KT-200 triggers a $45 million milestone payment to Kymera from Gilead...

March 26 Targeted Oncology

FDA Grants Fast Track Status to ALK-Degrading Molecular Glue TRI-611

FDA fast track designation applies to ALK+ NSCLC progressing after ≥2 ALK TKIs, reflecting limited post-lorlatinib therapeutic options and enabling more frequent FDA interactions and...

Never miss news about Glue

Track Glue and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Glue competitors & trending companies

Browse news for competitors to Glue and other trending companies.